A R T I C L E S
Giuseppone et al.
3
3
Mp 162-165 °C. 1H NMR: 8.57 (d, 3J ) 4.8 Hz, 2H), 8.0 2 (d, 3J )
7.56 (s, 2H), 7.43 (s, 4H), 7.32 (t, J ) 6.8 Hz, 4H), 7.20 (t, J ) 6.8
Hz, 4H), 7.17-7.15 (m, 2H), 7.14 (s, 2H), 4.01 (s, 6H), 3.92 (s, 12H),
3.79 (s, 6H), 3.39 (s, 6H). 13C NMR: 164.25, 163.70, 162.10, 161.90,
161.85, 160.85, 154.35, 152.55, 149.00, 139.95, 138.10, 137.15, 136.25,
134.95, 133.10, 130.55, 130.20, 128.65, 128.15, 127.90, 127.80, 124.80,
120.95, 105.10, 88.20, 60.85, 55.95, 30.10, 29.25. HRMS (ESi-TOF-
MS) m/z (%): calcd for C74H67N20O6 1331.5547 [M + H]+; found
1331.5512 (100) [M + H]+.
3
5.4 Hz, 2H), 7.54 (s, 1H), 7.73 (m, 3H), 7.21 (t, J ) 5.4 Hz, 1H),
6.95 (s, 1H), 3.96 (s, 6H), 3.90 (s, 3H), 3.77 (s, 3H), 3.42 (s, 3H). 13
C
NMR: 163.1, 155.1, 153.0, 149.3, 140.3, 137.0, 136.6, 136.4, 136.1,
122.9, 119.9, 105.3, 86.8, 60.9, 56.1, 29.8, 29.7. HRMS (ESi-TOF-
MS) m/z (%): calcd for C21H25N7O3 446.1916 [M + H]+; found
446.1750 (100) [M + Na]+.
2-Phenylpyrimidine-4,6-dicarboxaldehyde 4,4-Bis{methyl{6-[1-
methyl-2-(pyridin-2-ylmethylene)hydrazino]-2-(3,4,5-trimethoxy-
phenyl)pyrimidin-4-yl}hydrazone} 6,6-{[2-(3,4,5-Trimethoxyphen-
yl)pyrimidine-4,6-diyl]bis(methylhydrazone)} (17). To a solution of
4,6-bis(N-methylhydrazino)-2-(3,4,5-trimethoxyphenyl)pyrimidine A12b
(5 mg, 1.49 × 10-2 mmol) in a CHCl3 solution (0.8 mL) was added 35
(18.5 mg, 2.99 × 10-2 mmol). The solution was stirred at 60 °C
overnight under an atmosphere of argon. All of the solvent was then
removed under reduced pressure, and the residue was purified by flash
chromatography (silica gel, gradient of solvents: CHCl3 to CHCl3/
MeOH (95/5)) to give 17 (22 mg, 96%) as a yellow powder. Mp >
6,6′-(6,6′-(1E,1′E)-(2,2′-(2-(3,4,5-Trimethoxyphenyl)pyrimidine-
4,6-diyl)bis(2-methylhydrazin-2-yl-1-ylidene))bis(methan-1-yl-1-
ylidene)bis(2-phenylpyrimidine-6,4-diyl))di-2,2′-pyridine (31). To a
solution of 2-phenyl-6-(pyridin-2-yl)pyrimidine-4-carbaldehyde 54 (94
mg, 2.77 × 10-1 mmol) in CHCl3 (2 mL) was added 4,6-bis(N-
methylhydrazino)-2-(3,4,5-trimethoxyphenyl)pyrimidine A12b (46.4 mg,
1.38 × 10-1 mmol). The solution was stirred at room temperature
overnight under an atmosphere of argon. All of the solvent was then
removed under reduced pressure, and the residue was purified by flash
chromatography (silica gel, CHCl3) to give a mixture of 31 (top spot,
62 mg, 55%, yellow powder) and of the corresponding monohydrazine
33 (bottom spot, 38 mg, yellow powder). 31, Mp > 250 °C
(decomposition). 1H NMR: 8.95 (s, 2H), 8.73-8.63 (m, 4H), 8.22 (s,
1
3
250 °C (decomposition). H NMR: 8.39 (s, 2H), 8.20 (dd, J ) 8.6
Hz, 3J ) 1.2 Hz, 4H), 8.03 (d, 3J ) 4.3 Hz, 2H), 7.69 (d, 3J ) 7.8 Hz,
2H), 7.64 (d, 3J ) 5.8 Hz, 4H), 7.60 (s, 2H), 7.57 (s, 2H), 7.45 (s, 4H),
7.42 (s, 2H), 7.35 (t, 3J ) 7.4 Hz, 2H), 7.22 (t, 3J ) 7.0 Hz, 4H), 7.22
(s, 1H), 6.98 (t, 3J ) 7.4 Hz, 2H), 6.64 (dd, 3J ) 6.2 Hz, 3J ) 1.2 Hz,
2H), 4.10 (s, 6H), 4.02 (s, 3H), 4.00 (s, 6H), 3.89 (s, 12H), 3.80 (s,
6H), 3.68 (s, 12H).13C NMR: 164.45, 162.45, 162.00, 161.45, 161.30,
161.20, 161.05, 160.75, 153.75, 153.05, 152.60, 140.30, 140.05, 137.05,
135.50, 135.25, 135.15, 133.50, 133.10, 130.30, 127.95, 127.90, 122.00,
119.30, 106.95, 105.40, 105.15, 89.00, 87.30, 61.00, 60.85, 56.30, 55.95,
30.15, 30.05, 29.80. HRMS (ESi-TOF-MS) m/z (%): calcd for
C81H81N24O9 1533.6618 [M + H]+; found 1533.6625 (100) [M + H]+.
3
1H), 8.14 (d, J ) 7.9 Hz, 2H), 8.00 (s, 2H), 7.85 (s, 2H), 7.60-7.50
(m, 8H), 7.55 (td, 3J ) 7.6 Hz, 3J ) 1.7 Hz, 2H), 6.96 (ddd, 3J ) 7.3
Hz, 3J ) 4.7 Hz, 3J ) 1.2 Hz, 2H), 4.06 (s, 6H), 3.99 (s, 3H), 3.94 (s,
6H). 13C NMR: 164.00, 163.25, 162.80, 161.95, 153.85, 153.10, 153.00,
148.50, 137.95, 136.05, 135.25, 133.40, 130.60, 128.55, 128.20, 124.55,
120.80, 110.25, 105.45, 101.95, 89.10, 61.00, 56.20, 30.15. HRMS (ESi-
TOF-MS) m/z (%): calcd for C47H41N12O3 [M + H]+ 821.3419; found
821.3453 (100) [M + H]+. 33, H NMR: 8.84 (s, 1H), 8.76 (d, J )
3.9 Hz, 1H), 8.70 (d, J ) 8.2 Hz, 1H), 8.64 (m, 2H), 7.92 (td, J )
7.8 Hz, J ) 1.6 Hz, 2H), 7.85 (s, 1H), 7.76 (s, 2H), 7.58-7.55 (m,
1
3
3
3
3
(1E,1′E)-(2,2′-(6,6′-(2E,2′E)-2,2′-(2-Phenylpyrimidine-4,6-diyl)bis-
(methan-1-yl-1-ylidene)bis(1-methylhydrazin-1-yl-2-ylidene)bis(2-
(3,4,5-trimethoxyphenyl)pyrimidine-6,4-diyl))bis(2-methylhydrazin-
2-yl-1-ylidene))bis(methan-1-yl-1-ylidene)bis(2-phenylpyrimidine-
6,4-diyl))di-2,2′-bipyridine (29). 6-(2,2′-Bipyridin-6-yl)-2-phenylpyrimi-
dine-4-carbaldehyde 53 (30 mg, 8.9 × 10-2 mmol) and 4,6-bis(1-
methylhydrazinyl)-2-(3,4,5-trimethoxyphenyl)pyrimidine (30 mg, 0.089
mmol) were stirred in 2 mL of chloroform at 40 °C for 2 h under an
atmosphere of argon. 4,6-Diformyl-2-phenyl-pyrimidine (9.5 mg, 0.045
mmol) was then added and stirred at 40 °C for 12 h. After the solvent
was removed under reduced pressure, the residue was purified by
chromatography (Al2O3, CHCl3) to give 29 (15 mg, 23%) as a yellow
solid. Mp > 250 °C (decomposition). 1H NMR: 8.88 (s, 1H), 8,57 (d,
3J ) 8.0 Hz, 2H), 8.40 (d, 3J ) 7.2 Hz, 2H), 8.31 (d, 3J ) 7.2 Hz, 4H),
3
3
3
2H), 7.44 (ddd, J ) 7.0 Hz, J ) 4.7 Hz, J ) 1.2 Hz, 1H), 7.11 (s,
1H), 4.00 (s, 6H), 3.95 (s, 3H), 3.82 (s, 3H), 3.48 (s, 3H). 13C NMR:
165.40, 164.35, 163.25, 162.70, 162.50, 161.75, 154.60, 152.95, 149.40,
140.20, 137.75, 137.10, 134.55, 133.85, 130.65, 128.50, 128.25, 125.20,
121.95, 109.90, 105.35, 83.35, 60.95, 56.15, 39.70, 30.10, 28.25. HRMS
(ESi-TOF-MS) m/z (%): calcd for C31H32N9O3 578.2623 [M + H]+;
found 578.2625 (100) [M + H]+.
6,6′-(6,6′-(1E,1′E)-(2,2′-(2-(3,4,5-Trimethoxyphenyl)pyrimidine-
4,6-diyl)bis(2-methylhydrazin-2-yl-1-ylidene))bis(methan-1-yl-1-
ylidene)bis(2-phenylpyrimidine-6,4-diyl))di-2,2′-bipyridine (32). 6-(2,2′-
Bipyridin-6-yl)-2-phenylpyrimidine-4-carbaldehyde 53 (30 mg, 8.9 ×
10-2 mmol) and 4,6-bis(1-methylhydrazinyl)-2-(3,4,5-trimethoxyphen-
yl)pyrimidine (14.5 mg, 4.5 × 10-2 mmol) were stirred in 2 mL of
chloroform at 40 °C for 12 h under an atmosphere of argon. The solvent
was then removed under reduced pressure, and the residue was purified
by chromatography (Al2O3, CHCl3) to give 32 (30 mg, 69%) as a yellow
solid. Mp > 250 °C (decomposition). 1H NMR: 8.82 (s, 2H), 8.40 (m,
3
3
8.08 (m, 5H), 7.97 (t, J ) 8.0 Hz, 2H), 7.74 (s, 2H), 7.54 (d, J ) 6
3
Hz, 4H), 7.50 (s, 2H), 7.45 (s, 4H), 7.26 (m, 4H), 7.23 (t, J ) 8 Hz,
2H), 7.05 (s, 2H), 6.85 (s, 2H), 6.71 (m, 2H), 4.01 (s, 6H), 3.93 (s,
12H), 3.82 (s, 6H), 3.42 (s, 6H). 13C NMR: 164.04, 162.62, 162.49,
162.33, 161.348, 160.75, 155.693, 154.86, 153.83, 152.96, 148.62,
140.50, 138.41, 137.60, 137.41, 135.96, 135.62, 133.44, 130.59, 128.91,
128.62, 128.29, 123.67, 122.47, 121.39, 120.91, 109.44, 105.57, 87.65,
61.20, 56.34, 34.24, 32.24. HRMS (ESi-TOF-MS) m/z (%): calcd for
C84H73N22O6 1485.6078 [M + H]+; found 1485.6279 (100) [M + H]+.
3
4H), 8.19 (m, 7H), 8.08 (d, J ) 8.2 Hz, 2H), 7.86 (s, 2H), 7.80 (s,
2H), 7.64 (t, 3J ) 8.0 Hz, 2H), 7.55 (m, 6H), 7.36 (td, 3J ) 8.2 Hz, 3J
3
) 1.2 Hz, 2H), 6.93 (t, J ) 5.4 Hz, 2H), 4.09 (s, 6H), 4.01 (s, 3H),
3.90 (s, 6H). 13C NMR: 163.78, 163.30, 162.29, 162.23, 154.72, 154.53,
153.13, 152.80, 148.33, 137.78, 137.21, 136.32, 135.68, 132.91, 132.13,
132.04, 131.95, 130.34, 128.54, 128.42, 128.33, 128.28, 123.42, 121.91,
121.27, 120.28, 109.53, 105.51, 87.22, 60.99, 56.24, 30.25. HRMS (ESi-
TOF-MS) m/z (%): calcd for C57H46N14Na1O3 997.3770 [M + Na]+;
found 997.3771 (100) [M + Na]+.
(1E,1′E)-(2,2′-(6,6′-(2E,2′E)-2,2′-(2-Phenylpyrimidine-4,6-diyl)bis-
(methan-1-yl-1-ylidene)bis(1-methylhydrazin-1-yl-2-ylidene)bis(2-
(3,4,5-trimethoxyphenyl)pyrimidine-6,4-diyl))bis(2-methylhydrazin-
2-yl-1-ylidene))bis(methan-1-yl-1-ylidene)bis(2-phenylpyrimidine-
6,4-diyl))di-2,2′-pyridine (30). A solution of 33 (30.8 mg, 4.7 × 10-2
mmol) and 2-phenylpyrimidine-4,6-dicarboxaldehyde12b (5 mg, 2.35
× 10-2 mmol) in 1.2 mL of CHCl3 was stirred at room temperature
for 12 h under an argon atmosphere. Chloroform was then removed
under reduced pressure, and the residue was purified by flash chro-
matography (silica gel, CHCl3) to afford 30 (30 mg, 96%) as a pale
yellow powder. Mp > 250 °C (decomposition). 1H NMR: 8.75 (l, 2H),
8.55 (d, 3J ) 7.8 Hz, 4H), 8.47 (s, 1H), 8.29 (d, 3J ) 7.4 Hz, 4H), 7.96
Crystal Structure of 32 (CCDC 620830). A suitable crystal of 32
was obtained by diffusion-recrystallization from CHCl3 (solvent).
Diffraction data were collected at 173 K. Formula: C60H49Cl9N14O3d
C57H46N14O3‚3CHCl3. Molecular weight: 1333.18. Yellow crystal;
crystal size (mm): 0.18 × 0.14 × 0.10. Unit cell parameters: a )
13.8400 (3) Å, b ) 15.0840(3) Å, c ) 16.3080(4) Å, R ) 82.84(5)°,
â ) 70.59°(5), γ ) 75.03(5)°; crystal system, triclinic; space group
P-1; V ) 3099.2(1) Å3; F(000) ) 1368; Z ) 2; calculated density )
1.43 g cm-3; linear absorption coefficient µ ) 0.464 mm-1. Of 21 844
3
(l, 2H), 7.86 (t, J ) 6.4 Hz, 2H), 7.65 (s, 2H), 7.64-7.50 (m, 3H),
9
16760 J. AM. CHEM. SOC. VOL. 128, NO. 51, 2006